Carrier Screening Market Size, Share & Trends Report

Carrier Screening Market (2026 - 2033) Size, Share & Trends Analysis Report By Medical Conditions (Spinal Muscular Atrophy, Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease), By Type, By Technology, By End Use, By Region, And Segment Forecasts

Market Segmentation

Carrier Screening Medical Conditions Outlook (Revenue, USD Million, 2021 - 2033)
- Spinal Muscular Atrophy
- Cystic Fibrosis
- Tay-Sachs
- Gaucher Disease
- Sickle Cell Disease
- Others
Carrier Screening Type Outlook (Revenue, USD Million, 2021 - 2033)
- Expanded Carrier Screening
- Targeted Disease Carrier Screening
Carrier Screening Technology Outlook (Revenue, USD Million, 2021 - 2033)
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Other Technologies (MLPA, Genotyping, Enzyme Screening)
Carrier Screening End use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Laboratories
- Physician Offices & Clinics
- Other End Users
Carrier Screening Regional Outlook (USD Million, 2021 - 2033)
- North America
  - North America Carrier Screening Market, By Medical Conditions
    - Spinal Muscular Atrophy
    - Cystic Fibrosis
    - Tay-Sachs
    - Gaucher Disease
    - Sickle Cell Disease
    - Others
  - North America Carrier Screening Market, By Type
    - Expanded Carrier Screening
    - Targeted Disease Carrier Screening
  - North America Carrier Screening Market, By Technology
    - DNA Sequencing
    - Polymerase Chain Reaction
    - Microarrays
    - Other Technologies (MLPA, Genotyping, Enzyme Screening)
  - North America Carrier Screening Market, By End Use
    - Hospitals
    - Laboratories
    - Physician Offices & Clinics
    - Other End Users
  - U.S.
    - U.S. Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - U.S. Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - U.S. Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - U.S. Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Canada
    - Canada Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Canada Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Canada Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Canada Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Mexico
    - Mexico Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Mexico Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Mexico Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Mexico Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
- Europe
  - Europe Carrier Screening Market, By Medical Conditions
    - Spinal Muscular Atrophy
    - Cystic Fibrosis
    - Tay-Sachs
    - Gaucher Disease
    - Sickle Cell Disease
    - Others
  - Europe Carrier Screening Market, By Type
    - Expanded Carrier Screening
    - Targeted Disease Carrier Screening
  - Europe Carrier Screening Market, By Technology
    - DNA Sequencing
    - Polymerase Chain Reaction
    - Microarrays
    - Other Technologies (MLPA, Genotyping, Enzyme Screening)
  - Europe Carrier Screening Market, By End Use
    - Hospitals
    - Laboratories
    - Physician Offices & Clinics
    - Other End Users
  - UK
    - UK Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - UK Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - UK Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - UK Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Germany
    - Germany Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Germany Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Germany Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Germany Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - France
    - France Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - France Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - France Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - France Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Italy
    - Italy Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Italy Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Italy Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Italy Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Spain
    - Spain Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Spain Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Spain Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Spain Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Denmark
    - Denmark Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Denmark Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Denmark Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Denmark Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Norway
    - Norway Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Norway Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Norway Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Norway Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
- Asia Pacific
  - Asia Pacific Carrier Screening Market, By Medical Conditions
    - Spinal Muscular Atrophy
    - Cystic Fibrosis
    - Tay-Sachs
    - Gaucher Disease
    - Sickle Cell Disease
    - Others
  - Asia Pacific Carrier Screening Market, By Type
    - Expanded Carrier Screening
    - Targeted Disease Carrier Screening
  - Asia Pacific Carrier Screening Market, By Technology
    - DNA Sequencing
    - Polymerase Chain Reaction
    - Microarrays
    - Other Technologies (MLPA, Genotyping, Enzyme Screening)
  - Asia Pacific Carrier Screening Market, By End Use
    - Hospitals
    - Laboratories
    - Physician Offices & Clinics
    - Other End Users
  - Japan
    - Japan Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Japan Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Japan Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Japan Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - China
    - China Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - China Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - China Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - China Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - India
    - India Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - India Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - India Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - India Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Australia
    - Australia Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Australia Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Australia Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Australia Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - South Korea
    - South Korea Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - South Korea Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - South Korea Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - South Korea Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Thailand
    - Thailand Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Thailand Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Thailand Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Thailand Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
- Latin America
  - Latin America Carrier Screening Market, By Medical Conditions
    - Spinal Muscular Atrophy
    - Cystic Fibrosis
    - Tay-Sachs
    - Gaucher Disease
    - Sickle Cell Disease
    - Others
  - Latin America Carrier Screening Market, By Type
    - Expanded Carrier Screening
    - Targeted Disease Carrier Screening
  - Latin America Carrier Screening Market, By Technology
    - DNA Sequencing
    - Polymerase Chain Reaction
    - Microarrays
    - Other Technologies (MLPA, Genotyping, Enzyme Screening)
  - Latin America Carrier Screening Market, By End Use
    - Hospitals
    - Laboratories
    - Physician Offices & Clinics
    - Other End Users
  - Brazil
    - Brazil Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Brazil Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Brazil Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Brazil Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Argentina
    - Argentina Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Argentina Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Argentina Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Argentina Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
- Middle East & Africa
  - Middle East & Africa Carrier Screening Market, By Medical Conditions
    - Spinal Muscular Atrophy
    - Cystic Fibrosis
    - Tay-Sachs
    - Gaucher Disease
    - Sickle Cell Disease
    - Others
  - Middle East & Africa Carrier Screening Market, By Type
    - Expanded Carrier Screening
    - Targeted Disease Carrier Screening
  - Middle East & Africa Carrier Screening Market, By Technology
    - DNA Sequencing
    - Polymerase Chain Reaction
    - Microarrays
    - Other Technologies (MLPA, Genotyping, Enzyme Screening)
  - Middle East & Africa Carrier Screening Market, By End Use
    - Hospitals
    - Laboratories
    - Physician Offices & Clinics
    - Other End Users
  - South Africa
    - South Africa Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - South Africa Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - South Africa Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - South Africa Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Saudi Arabia
    - Saudi Arabia Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Saudi Arabia Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Saudi Arabia Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Saudi Arabia Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - UAE
    - UAE Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - UAE Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - UAE Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - UAE Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users
  - Kuwait
    - Kuwait Carrier Screening Market, By Medical Conditions
      - Spinal Muscular Atrophy
      - Cystic Fibrosis
      - Tay-Sachs
      - Gaucher Disease
      - Sickle Cell Disease
      - Others
    - Kuwait Carrier Screening Market, By Type
      - Expanded Carrier Screening
      - Targeted Disease Carrier Screening
    - Kuwait Carrier Screening Market, By Technology
      - DNA Sequencing
      - Polymerase Chain Reaction
      - Microarrays
      - Other Technologies (MLPA, Genotyping, Enzyme Screening)
    - Kuwait Carrier Screening Market, By End Use
      - Hospitals
      - Laboratories
      - Physician Offices & Clinics
      - Other End Users

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments